Drugs / MTX
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02067143 | May 2014 → Oct 2016 | precursor lymphoblastic lymphoma/leukemia | GIMEMA Foundation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX | “MTX + ARA-C” NCT02067143 ↗ |